FINDINGS:
Lungs: Clear lungs without focal mass. No suspicious nodules identified.
Mediastinum: Enlarged paratracheal lymph node, short axis 29 mm. Cardiomediastinal contours within normal limits. no mediastinal mass.
Pleura/Pleural spaces: No pleural effusion or pleural thickening.
Great vessels/Aorta: No thoracic aortic aneurysm or dissection.
Liver: 61 mm lobulated hepatic mass in segment 7 of the liver (hyperenhancing). No focal hepatic lesions. Normal attenuation. hemangioma (peripheral nodular enhancement with centripetal fill-in).
Spleen: Normal in size and attenuation. No focal splenic lesion. accessory spleen.
Pancreas: Normal pancreatic contour and enhancement. No focal mass.
Adrenal glands: Adrenal glands are normal without nodules.
Kidneys: No hydronephrosis. No enhancing renal mass. kidneys are normal.
GI tract/Bowel: No obstructive process. No focal bowel wall mass identified. no colonic mass.
Mesentery/Omentum: No ascites. No omental caking.
Mesenteric vessels (SMA/SMV): SMA/SMV are patent without thrombosis.
Urinary bladder: Unremarkable. urinary bladder normal.
Reproductive organs: No adnexal mass. Uterus/prostate within expected size for age. simple physiologic cyst. prostate is normal / no prostatic mass.
Lymph nodes: No pathologically enlarged lymph nodes by size criteria.
Bones/Osseous structures: 2.8 cm lesion in the bone, suspicious for metastasis. No aggressive osseous lesion. No acute fracture.

IMPRESSION:
- Liver primary malignancy at segment 7 of the liver measuring approximately 61 mm.
- Findings concerning for nodal involvement.
- Findings compatible with distant metastases involving: bone.
- RECIST 1.1 Summary:
- Target lesions (n=3; ≤2 per organ rule applied).
  • T1: Primary — 61 mm (longest diameter) at baseline.
  • T2: Metastasis — 28 mm (longest diameter) at baseline.
  • T3: Lymph node — 29 mm (short axis) at baseline.
- SLD baseline: 118 mm.
- New lesions: absent (unequivocal).
- - RECIST 1.1 overall response category: Baseline (no category).
